Empagliflozin Reduces Liver Fat Content Regardless of T2DM, Study Finds

Findings were presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases and showed empagliflozin reduced liver fat content in both patients with T2DM and nondiabetic patients.

Related Keywords

Boston ,Massachusetts ,United States ,Linkedin Siham Abdelgani ,Siham Abdelgani ,University Of Texas At San Antonio ,Liver Meeting ,American Association ,Liver Diseases ,San Antonio ,Empagliflozin ,Diabetes ,Type 2 Diabetes Mellitus ,Diabetes Mellitus ,Fatty Liver ,Fatty Liver Disease ,Nafld ,Nash ,Mafld ,Smash ,Empafgliflozin ,T2dm ,Liver Fat ,Hepatic Fat ,Reduction ,